Open AccessClaims for compensation from women with cervical cancer in Norway—A retrospective, descriptive study of a 12‐year period
Author(s) -
Ravlo Merethe,
Lieng Marit,
Khan Bukholm Ida Rashida,
Haase Moen Mette,
Vanky Eszter
Publication year - 2020
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1111/aogs.13930
Subject(s) - medicine , cervical cancer , retrospective cohort study , norwegian , medical record , cervix , cancer , obstetrics , gynecology , surgery , linguistics , philosophy
In Norway, all patient‐reported claims for compensation are evaluated by The Norwegian System of Patient Injury Compensation (NPE). The number of claims from women with cervical cancer is rising, and the approval rate is high. Our aim was to study claims for compensation from women with cervical cancer to identify the type of failures, when, during the time‐course of treatment, the medical failures occurred, and the consequences of the failures. Material and methods A retrospective, descriptive study of claims for compensation to NPE from cervical cancer patients during a 12‐year period, from 2007 through 2018. We used anonymized medical expert statements and summaries of NPE cases. Results In all, 161 women claimed compensation for alleged medical failure related to cervical cancer. Compensation was approved for 100 (62%) women. Mean age at the time of alleged failure was 37.5 years (SD ±9.9). The main reasons why women sought medical attention were routine cervical screening (56%), or vaginal bleeding or discharge (30%). In approved cases, incorrect evaluation of cytology and histology was the cause of most failures (72%). Mean delay of cervical cancer diagnosis for approved cases was 28 months (SD ±22). Treatment not in accordance with guidelines was the cause of failure in 2% of the cases, and failure during follow up was the cause of failure in 12%. Consequences of the failures were as follows: worsening of cancer prognosis (89%), treatment‐induced adverse effects, such as loss of fertility (43%) and/or loss of ovarian function in premenopausal women (50%), and permanent injury after chemo‐radiation (27%). Seven women (7%) died, most probably as a consequence of the failure. Conclusions The main cause of medical failure in women with cervical cancer was incorrect pathological diagnosis. The main consequences of failures were worsening of cancer prognosis and treatment‐induced adverse effects. Increased focus on the quality of pathological examinations, and better routines in all parts of the cervical examinations might improve patient safety for women in risk of cervical cancer.